CH Robinson (NASDAQ: CHRW) NAST president sells 2,849 shares in 10b5-1 trade

Rhea-AI Filing Summary

C.H. Robinson Worldwide executive Michael D. Castagnetto, President of NAST, sold 2,849 shares of common stock on February 2, 2026 at $194.20 per share under a pre-arranged Rule 10b5-1(c) trading plan adopted on November 3, 2025. After this sale, he beneficially owns 28,149 shares, including 25,407 shares issuable from restricted stock units and deferred shares in his NQDC Plan account and 2,742 shares held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Castagnetto Michael D.

(Last) (First) (Middle)

14701 CHARLSON ROAD

(Street)

EDEN PRAIRIE MN 55347

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
C. H. ROBINSON WORLDWIDE, INC. [ CHRW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres, NAST

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/02/2026		S(1)		2,849	D	$194.2	28,149(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Adoption date of referenced 10b5-1(c) plan is: 11-03-2025.

2. Included in this amount are 25,407 shares of Issuer common stock issuable in settlement of an equal number of restricted stock units and deferred shares credited to the reporting person's NQDC Plan account and 2,742 shares held directly by the reporting person.

	/s/ Nicole Strydom, Attorney-in-Fact for Michael D. Castagnetto	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CHRW executive Michael Castagnetto report?

Michael D. Castagnetto reported selling 2,849 shares of C.H. Robinson Worldwide common stock. The sale took place on February 2, 2026 at a price of $194.20 per share under a pre-arranged Rule 10b5-1(c) trading plan.

How many CHRW shares does Michael Castagnetto own after this Form 4?

After the reported transaction, Michael D. Castagnetto beneficially owns 28,149 CHRW shares. This includes 25,407 shares issuable from restricted stock units and deferred shares in his NQDC Plan account and 2,742 shares held directly.

Was the CHRW insider sale by Michael Castagnetto under a 10b5-1 plan?

Yes. The sale of 2,849 CHRW shares on February 2, 2026 was executed under a Rule 10b5-1(c) trading plan. The filing notes the plan’s adoption date as November 3, 2025, indicating it was pre-arranged rather than opportunistic.

What price did Michael Castagnetto receive for his CHRW share sale?

He received $194.20 per share for the 2,849 CHRW shares sold. The transaction code is “S,” indicating an open-market or private sale of non-derivative common stock, as disclosed in the Form 4’s Table I section.

What is Michael Castagnetto’s role at C.H. Robinson Worldwide (CHRW)?

Michael D. Castagnetto is identified as an officer of C.H. Robinson Worldwide with the title “Pres, NAST.” This indicates he serves as President of the company’s NAST business segment, according to the relationships section of the Form 4.

How are restricted stock units reflected in Michael Castagnetto’s CHRW holdings?

His reported 28,149 beneficially owned CHRW shares include 25,407 shares issuable upon settlement of restricted stock units and deferred shares. These are credited to his NQDC Plan account, alongside 2,742 shares that he holds directly as common stock.